Debra Messing said during her 'Today' show interview that her 'The Alto Knights' costar, Robert De Niro's real-life pet dogs ...

Q4 2024 Earnings Call Transcript March 18, 2025 MiNK Therapeutics, Inc. misses on earnings expectations. Reported EPS is ...

MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the development of allogeneic, ...

Vectors for Infection Risk in the United States Act (Mink VIRUS Act), bipartisan legislation endorsed by the Animal Welfare ...

MiNK advanced its mission to bring off-the-shelf iNKT cell therapies to patients fighting hard-to-treat cancers and severe ...

MiNK Therapeutics (NASDAQ:INKT – Get Free Report)‘s stock had its “buy” rating reaffirmed by investment analysts at HC Wainwright in a report issued on Tuesday,Benzinga reports. They currently have a ...

Hello, everyone, and welcome to MiNK Therapeutics fourth-quarter 2024 financial results call. Please note that this call is being recorded. (Operator Instructions) I'd now like to hand the call over ...

Patsy Takemoto Mink shattered barriers as the first Asian American woman in Congress and a champion of Title IX. Now, her ...

SPRINGFIELD, Ill. (WAND) — A bill filed by a State House Democrat would add regulations on an unregulated minx fur trade in ...

Big culinary experiences are emerging in small town Wisconsin, from a supper club with a vinyl lounge to an inn and ...

MiNK Therapeutics Inc (INKT) showcases promising clinical progress and strategic partnerships while navigating financial hurdles and leadership changes.

NEW YORK, March 18, 2025 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf invariant ...